PRCT Element – Stock Valuation Based – Benjamin Graham
Below is the most important legend of Guru Valide for PROCEPT BIOROBOTICS CORP (PRCT). Of the 22 guru systems we train, PRCT is the absolute best using our Stamp Investor model based on Benjamin Graham’s broadcast strategy. This deep pricing methodology tracks stocks that regain low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
PROCEPT BIOROBOTICS CORP (PRCT) is a mid-cap stock in the Clinical Equipment & Affords trade. The ranking based on this draw is 57% based on the agency’s fundamentals and stock valuation. Receiving 80% or more usually means that the technique has some passion in the stock, and receiving above 90% usually indicates stable passion.
The following table summarizes whether a stock meets all the tests of this draw. Now, not all of the standards in the table below have equal weight or are dependent on each other, but the table provides a passing overview of stable and worn security choices in the context of engineering standards.
SECTOR: | PASS |
SALE: | FAILED |
CURRENT RELATIONSHIP: | PASS |
LONG-TERM DEBT BASED ON NET WORKING ASSETS: | PASS |
LONG-TERM EPS GROWTH: | FAILED |
P/E RATIO: | PASS |
PRICE/BOOK RATIO: | FAILED |
Detailed evaluation of PROCEPT BIOROBOTICS CORP
PRCT Guru rating
Main score of PRCT
More information about Benjamin Graham
Benjamin Graham Portfolio
Benjamin Graham’s Best Stocks
About Benjamin Graham: The laid-back Benjamin Graham could probably be the oldest of the gurus we educate, but his influence on the investment world has lasted long after his death in 1976. Identified as the “Father of Brand Investing” and the founder of the complete self-discipline of security diagnosis, Graham mentored more greatest traders in historical past — including Warren Buffett — and inspired a host of others, including John Templeton, Mario Gabelli, and another Valide guru, John Neff. Graham gained his wealth and notoriety after going through some extremely nervous times, including the Great Depression and his coming to terms with the family’s financial problems after his father’s death when Benjamin was a young man. His funding agency posted annual returns of around 20% from 1936 to 1956, well above the market’s 12.2% practical return at one point shortly during that time.
Additional research links
The best healthcare stocks
Dividend Aristocrats 2025
Stocks of a wide ditch
Recession-proof stocks
Excessive internal ownership stocks
Stock portfolios based primarily on elements
About Validea: Validea is an investment research service that follows funding legend broadcast systems. Validea offers all-stock diagnosis and model portfolios based on gurus who have outperformed the market over the long term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are those of the creator and reflect, but do not necessarily judge, the views and opinions of Nasdaq, Inc.
Post Comment